Company Filing History:
Years Active: 2017-2020
Title: **Stefano Luca Giaffreda: Innovator in Pharmaceutical Crystallization**
Introduction
Stefano Luca Giaffreda, an accomplished inventor based in Medicina, Italy, has made significant contributions to the field of pharmaceutical innovations. With a total of two registered patents, his work demonstrates a commitment to enhancing drug formulations through novel crystallization techniques.
Latest Patents
Giaffreda's most recent patents focus on the development of unique crystalline forms of important pharmaceutical compounds. His first patent addresses the creation of novel crystalline forms of lenvatinib, specifically presenting crystalline forms of 4-[3-Chloro-4-(N'-cyclopropylureido)phenoxy]-7-methoxyquinoline-6-carboxamide methanesulfonate, along with methods for their preparation. The second patent pertains to the antidepressant compound vortioxetine hydrobromide, detailing three new crystalline forms. This patent not only outlines a process for their preparation but also introduces a pharmaceutical composition containing these novel forms and a purification method for vortioxetine or its salts.
Career Highlights
Throughout his career, Giaffreda has worked with reputable companies such as Dipharma Francis S.r.l. and Indena S.p.a.. These experiences have provided him with a solid foundation in the pharmaceutical industry and have allowed him to apply his expertise in drug formulation to practical applications.
Collaborations
In his journey as an inventor, Giaffreda has collaborated with notable colleagues, including Pietro Allegrini and Marco Curzi. These partnerships have likely enhanced the creative and technical aspects of his inventions, leading to successful patent applications.
Conclusion
Stefano Luca Giaffreda is a notable figure in the realm of pharmaceutical innovation. With a focus on crystalline forms of critical drug compounds, his patents have the potential to influence the effectiveness and manufacturing processes of medications. His work exemplifies the importance of dedicated research and collaboration in advancing pharmaceutical science.